Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
金斯瑞價格不尋常波動 重申每手2,000股臨時櫃檯周三收市後關閉
2026-11-04T  
石藥集團SYS 6088及SYH2072片臨床試驗在中國首個研究中心正式啟動
2026-11-04T  
石四藥奇霉素分散片獲批通過仿製藥質量和療效一致性評價
2026-11-03T  
石藥集團SYS 6057及SYS 6052臨床試驗在中國正式啟動
2026-11-03T  
《大行》花旗:中國製藥及生物科技ESMO數據再獲驗證 看好石藥、恆瑞、信達生物及科倫博泰
2026-11-02T  
石藥SYS 6043用於治療晚期實體瘤臨床試驗在中國首間中心正式啟動
2026-11-02T  
石四藥蘋果酸奈諾沙星獲准登記為原料藥
2026-10-29T  
石藥SYS6077注射液治療晚期惡性腫瘤I期臨床試驗在中國首家研究中心啟動
2026-10-29T  
《業績》白雲山首三季淨利潤24.92億人幣倒退24.73%
2026-10-29T  
《業績》山東新華製藥首三季淨利潤1.95億元人民幣倒退23.88%
2026-10-28T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.